n-Hexano, mínimo 95%, para síntesis, 2,5 L, envase de vidrio

1,5-DIMETHYL-4-NITROIMIDAZOLE, 97.0%, 100mg

Nimodipine, >98%, 5g

6-BROMO-5-CYANO-NICOTINIC ACID ETHYL ESTER, 95.0%, 5g

2,4-Dichloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 1g

(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexane)]-4-carbonitrile, 97%, 10g

2',5'-DIDEOXYADENOSINE, 95%, 25mg

7-Chlorothieno[2,3-c]pyridine, 95.0%, 250mg

3-Bromo-4-methoxyaniline, 98.0%, 500g

N6-Butyryl-L-lysine, 97%, 250mg

3-(2,3,4-Trimethoxyphenyl)propanoic acid, 95.0%, 1g

Allyl alpha-D-galactopyranoside, 95.0%, 25g

GMQ, 100mg